Carbonic Anhydrase Inhibitor class drugs

2 results
Zydus Lifesciences Limited

Keveyis (dichlorphenamide)

(Dichlorphenamide)
Xeris Pharmaceuticals, Inc.
Usage: KEVEYIS is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.